1. Home
  2. ABUS vs PDS Comparison

ABUS vs PDS Comparison

Compare ABUS & PDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbutus Biopharma Corporation

ABUS

Arbutus Biopharma Corporation

HOLD

Current Price

$4.56

Market Cap

848.8M

Sector

Health Care

ML Signal

HOLD

Logo Precision Drilling Corporation

PDS

Precision Drilling Corporation

HOLD

Current Price

$88.75

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABUS
PDS
Founded
2005
1951
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
848.8M
1.3B
IPO Year
2008
1998

Fundamental Metrics

Financial Performance
Metric
ABUS
PDS
Price
$4.56
$88.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$5.00
$122.33
AVG Volume (30 Days)
1.2M
91.8K
Earning Date
05-14-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
55.26
N/A
EPS
0.87
N/A
Revenue
$14,083,000.00
N/A
Revenue This Year
N/A
$5.66
Revenue Next Year
$239.71
$2.31
P/E Ratio
$5.28
$884.15
Revenue Growth
128.21
N/A
52 Week Low
$3.04
$43.50
52 Week High
$5.10
$103.80

Technical Indicators

Market Signals
Indicator
ABUS
PDS
Relative Strength Index (RSI) 57.10 41.82
Support Level $4.16 $87.74
Resistance Level $4.60 $92.40
Average True Range (ATR) 0.18 3.18
MACD 0.04 -0.72
Stochastic Oscillator 67.81 5.60

Price Performance

Historical Comparison
ABUS
PDS

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes imdusiran (AB-729), a GalNAc-conjugated, subcutaneously delivered ribonucleic acid interference (RNAi) therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

About PDS Precision Drilling Corporation

Precision Drilling Corp is a provider of contract drilling, completion, and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. The company operates through two industry segments: Contract Drilling Services, which generates maximum revenue and includes drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale, and repair of drilling equipment; and Completion and Production Services, which includes service rigs, oilfield equipment rental, and camp services. The company generates the majority of its revenue from the United States.

Share on Social Networks: